MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Land |
 Vereinigte Staaten |
IPO-Jahr |
2019 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
59.3 M |
Marktkapitalisierung |
$ 390 M |
EBITDA (LTM) |
$ -66.9 M |
P/E (LTM) |
-5.1 |
P/S (LTM) |
5.0 |
EPS (LTM) |
-1.29 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
$ 115.48 | 0.82 % | $ 35.1 B | NYSE,SPB | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
$ 16.2 | -0.61 % | $ 175 M | Nasdaq Global Market |  China |
|
Biodesix
BDSX
|
$ 15.07 | 2.1 % | $ 1.95 B | Nasdaq Global Market | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Co-Diagnostics
CODX
|
$ 4.4 | 101.83 % | $ 5.85 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Castle Biosciences
CSTL
|
$ 24.84 | -0.84 % | $ 690 M | Nasdaq Global Market,SPB | USA |
 |
DarioHealth Corp.
DRIO
|
$ 8.4 | 3.7 % | $ 33.5 M | Nasdaq Capital Market | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
BioNano Genomics
BNGO
|
$ 1.2 | 0.84 % | $ 6.53 M | Nasdaq Capital Market,SPB | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Charles River Laboratories International
CRL
|
$ 173.89 | -0.58 % | $ 8.62 B | NYSE,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
DexCom
DXCM
|
$ 62.22 | -0.24 % | $ 24.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 16.82 | 2.31 % | $ 509 M | Nasdaq Global Market | USA |
 |
Biomerica
BMRA
|
$ 2.17 | -0.91 % | $ 4.98 M | Nasdaq Capital Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Celcuity
CELC
|
$ 112.63 | -0.27 % | $ 5.27 B | Nasdaq Global Select Market | USA |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 198.02 | 0.17 % | $ 22 B | NYSE,SPB | USA |
 |
Guardant Health
GH
|
$ 93.83 | 2.94 % | $ 11.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Lantheus Holdings
LNTH
|
$ 76.1 | 0.53 % | $ 5.14 B | Nasdaq Global Select Market,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Medpace Holdings
MEDP
|
$ 498.34 | 1.81 % | $ 14.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Interpace Biosciences
IDXG
|
$ 1.96 | 5.82 % | $ 8.67 M | Nasdaq Global Select Market | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 259.94 | -1.11 % | $ 26 B | NYSE,SPB |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
$ 114.19 | 2.49 % | $ 9.42 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
$ 569.55 | 0.87 % | $ 45.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 9.41 | 0.21 % | $ 2.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Illumina
ILMN
|
$ 127.38 | 0.59 % | $ 20.3 B | Nasdaq Global Select Market,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 173.26 | 0.5 % | $ 29.8 B | NYSE,SPB | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.34 | -0.74 % | $ 402 M | Nasdaq Global Select Market,SPB | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 27.11 | -0.66 % | $ 20 B | NYSE |  Niderland |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 273.72 | 0.36 % | $ 22.8 B | NYSE,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 4.75 | 3.49 % | $ 440 M | Nasdaq Global Select Market,SPB | USA |
 |
Sotera Health Company
SHC
|
$ 14.96 | 0.61 % | $ 4.25 B | Nasdaq Global Select Market | USA |
 |
NeoGenomics
NEO
|
$ 8.0 | 3.23 % | $ 1.02 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 17.16 | -1.04 % | $ 384 M | Nasdaq Global Select Market | USA |